Literature DB >> 27436926

Recurrent renal giant leiomyosarcoma.

Salih Erpulat Öziş1, Kamil Gülpınar1, Zafer Şahlı1, Baha Burak Konak1, Mete Keskin1, Süleyman Özdemir1, Ömür Ataoğlu2.   

Abstract

Primary renal leiomyosarcomas are rare, aggressive tumors. They constitute 1-2% of adult malignant renal tumors. Although leiomyosarcomas are the most common histological type (50-60%) of renal sarcomas, information on renal leiomyosarcoma is limited. Local or systemic recurrences are common. The radiological appearance of renal leiomyosarcomas is not specific, therefore renal leiomyosarcoma cannot be distinguished from renal cell carcinoma by imaging methods in all patients. A 74-year-old female patient presented to our clinic complaining of a palpable mass on the right side of her abdomen in November 2012. The abdominal magnetic resonance imaging revealed a mass, 25 × 24 × 23 cm in size. Her past medical history revealed that she has undergone right radical nephrectomy in 2007, due to a 11 × 12 × 13 cm renal mass that was then reported as renal cell carcinoma on abdominal magnetic resonance imaging, but the pathological diagnosis was low-grade renal leiomyosarcoma. The most recent follow-up of the patient was in 2011, with no signs of local recurrence or distant metastases within this four-year period. The patient underwent laparotomy on November 2012, and a 35 cm retroperitoneal mass was excised. The pathological examination of the mass was reported as high-grade leiomyosarcoma. The formation of this giant retroperitoneal mass in 1 year can be explained by the transformation of the lesion's pathology from low-grade to a high-grade tumor.

Entities:  

Keywords:  Leiomyosarcoma; kidney; recurrence

Year:  2014        PMID: 27436926      PMCID: PMC4942162          DOI: 10.5152/UCD.2014.2153

Source DB:  PubMed          Journal:  Ulus Cerrahi Derg        ISSN: 1300-0705


  13 in total

Review 1.  Update on gemcitabine and docetaxel combination therapy for primary and metastatic sarcomas.

Authors:  Martee L Hensley
Journal:  Curr Opin Oncol       Date:  2010-07       Impact factor: 3.645

Review 2.  Prognostic factors in uterine sarcoma.

Authors:  Angiolo Gadducci
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2011-07-18       Impact factor: 5.237

3.  [Primary leiomyosarcoma of the kidney: a clinicopathological study of 13 cases at a high-volume institution].

Authors:  Zi-Bing Xiong; Ming Shi; Ashok Kunwar; Ni Chen; Peng Zhang; Hao Zeng; Xiang Li
Journal:  Sichuan Da Xue Xue Bao Yi Xue Ban       Date:  2012-01

Review 4.  Renal leiomyosarcoma: report of three cases and review of the literature.

Authors:  N Kavantzas; P M Pavlopoulos; I Karaitianos; E Agapitos
Journal:  Arch Ital Urol Androl       Date:  1999-12

5.  Clinicopathological prognostic factors in soft tissue leiomyosarcoma: a multivariate analysis.

Authors:  K Miyajima; Y Oda; Y Oshiro; S Tamiya; N Kinukawa; K Masuda; M Tsuneyoshi
Journal:  Histopathology       Date:  2002-04       Impact factor: 5.087

6.  Primary leiomyosarcoma of the kidney: a clinicopathologic study of 27 cases.

Authors:  Jeremy S Miller; Ming Zhou; Fadi Brimo; Charles C Guo; Jonathan I Epstein
Journal:  Am J Surg Pathol       Date:  2010-02       Impact factor: 6.394

7.  Leiomyosarcoma arising from the blind end of a bifid renal pelvis.

Authors:  Yeun-Goo Chung; Seok-Chan Kang; Sang-Min Yoon; Ji-Young Han; Do-Hwan Seong
Journal:  Yonsei Med J       Date:  2007-06-30       Impact factor: 2.759

8.  Differential diagnosis of smooth muscle tumors utilizing p53, pTEN and Ki-67 expression with estrogen and progesterone receptors.

Authors:  Hüsnü Gökaslan; Levent Türkeri; Zehra Neşe Kavak; Funda Eren; Alper Sişmanoğlu; Sennur Ilvan; Fatih Durmuşoğlu
Journal:  Gynecol Obstet Invest       Date:  2004-09-20       Impact factor: 2.031

9.  Primary renal sarcoma in adults. A natural history and management study by the American Cancer Society, Illinois Division.

Authors:  N J Vogelzang; A M Fremgen; P D Guinan; J S Chmiel; J L Sylvester; S F Sener
Journal:  Cancer       Date:  1993-02-01       Impact factor: 6.860

10.  Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing.

Authors:  Françoise Ducimetière; Antoine Lurkin; Dominique Ranchère-Vince; Anne-Valérie Decouvelaere; Michel Péoc'h; Luc Istier; Philippe Chalabreysse; Christine Muller; Laurent Alberti; Pierre-Paul Bringuier; Jean-Yves Scoazec; Anne-Marie Schott; Christophe Bergeron; Dominic Cellier; Jean-Yves Blay; Isabelle Ray-Coquard
Journal:  PLoS One       Date:  2011-08-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.